Indomethacin NDC 65162-506

NDC codes

FDA NDC Directory

Product NDC (as listed)65162-506Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65162-0506Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65162-506-03	65162050603	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-506-03)Marketed from Dec 6, 2010
65162-506-06	65162050606	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-506-06)Marketed from Dec 6, 2010
65162-506-09	65162050609	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-506-09)Marketed from Dec 6, 2010
65162-506-10	65162050610	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-506-10)Marketed from Dec 6, 2010
65162-506-11	65162050611	1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-506-11)Marketed from Dec 6, 2010
65162-506-50	65162050650	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-506-50)Marketed from Dec 6, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Indomethacin
Generic name (nonproprietary): indomethacin
Active ingredients: Indomethacin — 75 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Amneal Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091549
Marketing start: Dec 6, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 65162-506_083ef389-551a-48c5-9a92-f16fb6270ae4SPL ID 083ef389-551a-48c5-9a92-f16fb6270ae4SPL set ID dbad7e61-2347-43b1-a422-9183e41c10eaRxCUI 310992UNII XXE1CET956UPC 0365162506105
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465162050603 followed by a unit qualifier and the quantity

Package 65162-0506-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 15, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Indomethacin extended-release capsules are indicated for: Moderate to severe rheumatoid arthritis including acute flares of chronic disease Moderate to severe ankylosing spondylitis Moderate to severe osteoarthritis Acute painful shoulder (bursitis and/or tendinitis) Indomethacin extended-release capsules are a nonsteroidal anti-inflammatory drug indicated for: Moderate to severe rheumatoid arthritis including acute flares of chronic disease. Moderate to severe ankylosing spondylitis. Moderate to severe osteoarthritis. Acute painful shoulder (bursitis and/or tendinitis). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)